Paste your Google Webmaster Tools verification code here
Aurigene is a specialized biotech company, focused on oncology and inflammatory diseases. The company has collaborated with 6 of the top 10 pharma companies, and 10 industry leaders around the world, working on over 40 targets over the last 9 years; this has resulted in 8 compounds in early clinical development/ IND filing phase so far. The company is moving ahead with a mission to be the most respected and valued biotech company in India, exemplified through a pipeline of compounds in clinical development addressing critical needs in Oncology, Inflamma-tory disorders and Anti-infectives.
At BioAsia 2015, the CEO of Aurigene, Mr. CSN Murthy, converses with Biotecnika and provides some insights on the Company’s products and services, its growth story, expansion plans and upcoming research projects.
As the economy expands, probably the health care sector would expand much faster than the rest of the economy. Every time we see growth in per capita GDP, the dispro-portionate money will flow into the healthcare
12pt;">Source: Biotecnika Magazine- Issue March 2015
Shekhar Suman is a Serial Entrepreneur and the Co-Founder of Biotecnika. Magazine is a way he wants to recraft the way industry opines and expresses its views. With years of experience under his belt, he captains the ship with prudence and perfection. He is the chief-editor of Biotecnika Magazine and a big inspiration to the bio-community.
Quite an interview!!
Your email address will not be published. Required fields are marked *
Notify me of follow-up comments by email.
Notify me of new posts by email.
2014 Powered By Wordpress, Goodnews Theme By Momizat Team